NOV 28, 2015 10:56 AM PST

Functional Human Liver Cells Successfully Grown in Lab

WRITTEN BY: Julianne Chiaet
A group of German and Israeli scientists have successfully grown human liver cells in the laboratory that did not lose their metabolic function.  

The cells, called hepatocytes, make up about 80 percent of the liver’s mass. The human liver is the only organ that has the ability to rapidly regenerate lost tissue. As little as 25 percent of a liver can regenerate into a whole liver.

Unfortunately, hepatocytes lose their regenerative ability when removed from the body. Scientists who previously tried to tackle the problem ended up with cancer cells with little metabolic function. This inability has been a major obstacle for scientific, clinical and pharmaceutical development.
 
Fluorescently labeled polarized Upcyte® hepatocytes.

The scientists based their research on the German Cancer Research Center’s early work on HPV. They demonstrated that weak expression of Human Papilloma Virus (HPV) E6 and E7 proteins released hepatocytes from cell-cycle arrest, a stopping point in the cell cycle. The expression allowed the released hepatocytes to rapidly increase in response to Oncostatin M (OSM), a protein important in liver regeneration. Thus, the stimulation of OSM caused the cells to rapidly multiply.

They were careful to select colonies of human hepatocytes that only rapidly multiplied in response to OSM. The cells doubling time was 33 to 49 hours. Removal of OSM caused the cell to stop growing and, within 4 days, become highly functional liver cells. The method, called the upcyte© process, allows the cells to double 35 times since their primary isolation in the lab; resulting in approximately 1015 quadrillion cells from each liver isolation.


The strength of method lies in its ability to generate liver cells from multiple donors of ethnically diverse backgrounds, said biochemist Joris Braspenning, who led the German group. "[It enables] the study of patient-to-patient variability and idiosyncratic toxicity."

“Our technology will enable thousands of laboratories to study fatty liver disease, viral hepatitis, drug toxicity and liver cancer at a fraction of the current cost,” lead author and biomedical engineer Yaakov Nahmias said. The pharmaceutical industry routinely uses human hepatocytes when studying the major problem of hepatotoxicity, liver damage caused by a chemical or medicine. It is the most common reason for a drug to be withdrawn from the market. The development could additionally advance creating bio-artificial liver support for patients awaiting transplantations. 

The study was published online on October 26, 2015, by the journal Nature Biotechnology.

Source: The Hebrew University of Jerusalem via Science Daily
 
About the Author
  • Julianne (@JuliChiaet) covers health and medicine for LabRoots. Her work has been published in The Daily Beast, Scientific American, and MailOnline. While primarily a science journalist, she has also covered culture and Japanese organized crime. She is the New York Board Representative for the Asian American Journalists Association (AAJA). • To read more of her writing, or to send her a message, go to Jchiaet.com
You May Also Like
OCT 06, 2020
Immunology
COVID Triggers Abnormalities in Immune Monocytes
OCT 06, 2020
COVID Triggers Abnormalities in Immune Monocytes
University of Manchester immunologists are the first to make an interesting observation about the white blood cells of p ...
OCT 05, 2020
Cell & Molecular Biology
Gaining Insight Into the Connection Between Depression and Stress
OCT 05, 2020
Gaining Insight Into the Connection Between Depression and Stress
Depression is a common mental illness, and stress is known to be an environmental influence that can increase the risk o ...
OCT 15, 2020
Immunology
The Immune Cells Giving Menopausal Women Higher BPs
OCT 15, 2020
The Immune Cells Giving Menopausal Women Higher BPs
In general, men have higher blood pressures than women, giving them an increased risk of developing heart disease. After ...
OCT 19, 2020
Genetics & Genomics
Early Childhood Trauma Affects Metabolism in the Next Generation
OCT 19, 2020
Early Childhood Trauma Affects Metabolism in the Next Generation
Traumatic experiences can have a lasting impact, and kids that suffer through them can feel the effects for a lifetime. ...
OCT 19, 2020
Plants & Animals
Genetically Engineered Foods Could Alleviate Nutritional Deficiencies
OCT 19, 2020
Genetically Engineered Foods Could Alleviate Nutritional Deficiencies
There are over two billion people around the world that don't get the recommended levels of minerals and vitamins in ...
OCT 22, 2020
Health & Medicine
Vaping of Nicotine and Cannabis Mirror Each Other in Young People
OCT 22, 2020
Vaping of Nicotine and Cannabis Mirror Each Other in Young People
A new study has looked at whether nicotine and cannabis vaping follow similar trajectories from adolescence through to y ...
Loading Comments...